Search Results - "Wong, Yu‐Ning"

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer by Sweeney, Christopher J, Chen, Yu-Hui, Carducci, Michael, Liu, Glenn, Jarrard, David F, Eisenberger, Mario, Wong, Yu-Ning, Hahn, Noah, Kohli, Manish, Cooney, Matthew M, Dreicer, Robert, Vogelzang, Nicholas J, Picus, Joel, Shevrin, Daniel, Hussain, Maha, Garcia, Jorge A, DiPaola, Robert S

“…In this trial, the addition of six cycles of docetaxel to androgen-deprivation therapy resulted in longer median progression-free and overall survival than…”
Get full text

Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial by Rini, Brian I, Prof, Dorff, Tanya B, MD, Elson, Paul, ScD, Rodriguez, Cristina Suarez, MD, Shepard, Dale, MD, Wood, Laura, MSN, Humbert, Jordi, BSc, Pyle, Linda, RN, Wong, Yu-Ning, MD, Finke, James H, Prof, Rayman, Patricia A, MS, Larkin, James M G, FRCP, Garcia, Jorge A, MD, Plimack, Elizabeth R, MD

“…Summary Background A subset of patients with metastatic renal-cell carcinoma show indolent growth of metastases. Because of the toxicity and non-curative…”
Get full text

Clinicopathologic features, patterns of recurrence, and survival among women with triple‐negative breast cancer in the National Comprehensive Cancer Network by Lin, Nancy U., Vanderplas, Ann, Hughes, Melissa E., Theriault, Richard L., Edge, Stephen B., Wong, Yu‐Ning, Blayney, Douglas W., Niland, Joyce C., Winer, Eric P., Weeks, Jane C.

“…BACKGROUND: The objective of this study was to describe clinicopathologic features, patterns of recurrence, and survival according to breast cancer subtype…”
Get full text

Subtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer Survival by Partridge, Ann H, Hughes, Melissa E, Warner, Erica T, Ottesen, Rebecca A, Wong, Yu-Ning, Edge, Stephen B, Theriault, Richard L, Blayney, Douglas W, Niland, Joyce C, Winer, Eric P, Weeks, Jane C, Tamimi, Rulla M

“…Young women are at increased risk for developing more aggressive subtypes of breast cancer. Although previous studies have shown a higher risk of breast cancer…”
Get full text

Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle‐invasive bladder cancer by Galsky, Matthew D., Pal, Sumanta K., Chowdhury, Simon, Harshman, Lauren C., Crabb, Simon J., Wong, Yu‐Ning, Yu, Evan Y., Powles, Thomas, Moshier, Erin L., Ladoire, Sylvain, Hussain, Syed A., Agarwal, Neeraj, Vaishampayan, Ulka N., Recine, Federica, Berthold, Dominik, Necchi, Andrea, Theodore, Christine, Milowsky, Matthew I., Bellmunt, Joaquim, Rosenberg, Jonathan E.

“…BACKGROUND Gemcitabine plus cisplatin (GC) has been adopted as a neoadjuvant regimen for muscle‐invasive bladder cancer despite the lack of Level I evidence in…”
Get full text

Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial by Haas, Naomi B, Dr, Manola, Judith, MS, Uzzo, Robert G, Prof, Flaherty, Keith T, MD, Wood, Christopher G, Prof, Kane, Christopher, Prof, Jewett, Michael, Prof, Dutcher, Janice P, Prof, Atkins, Michael B, Prof, Pins, Michael, Prof, Wilding, George, Prof, Cella, David, Prof, Wagner, Lynne, Prof, Matin, Surena, Prof, Kuzel, Timothy M, Prof, Sexton, Wade J, Prof, Wong, Yu-Ning, MD, Choueiri, Toni K, MD, Pili, Roberto, Prof, Puzanov, Igor, MD, Kohli, Manish, MD, Stadler, Walter, Prof, Carducci, Michael, Prof, Coomes, Robert, DiPaola, Robert S, Prof

“…Summary Background Renal-cell carcinoma is highly vascular, and proliferates primarily through dysregulation of the vascular endothelial growth factor (VEGF)…”
Get full text

Evaluating Overall Survival and Competing Risks of Death in Patients With Localized Renal Cell Carcinoma Using a Comprehensive Nomogram by KUTIKOV, Alexander, EGLESTON, Brian L, WONG, Yu-Ning, UZZO, Robert G

“…Many patients with localized node-negative renal cell carcinoma (RCC) are elderly with competing comorbidities. Their overall survival benefit after surgical…”
Get full text

Long‐term depression incidence and associated mortality among African American and White prostate cancer survivors by Parikh, Ravi B., Gallo, Joseph J., Wong, Yu‐Ning, Robinson, Kyle W., Cashy, John P., Narayan, Vivek, Jayadevappa, Ravishankar, Chhatre, Sumedha

“…Background Depression is common after a diagnosis of prostate cancer and may contribute to poor outcomes, particularly among African Americans. The authors…”
Get full text

Trends in radical prostatectomy: centralization, robotics, and access to urologic cancer care by Stitzenberg, Karyn B., Wong, Yu‐Ning, Nielsen, Matthew E., Egleston, Brian L., Uzzo, Robert G.

“…BACKGROUND: Robotic surgery has been widely adopted for radical prostatectomy. We hypothesized that this change is rapidly shifting procedures away from…”
Get full text

Time to Surgery and Breast Cancer Survival in the United States by Bleicher, Richard J, Ruth, Karen, Sigurdson, Elin R, Beck, J Robert, Ross, Eric, Wong, Yu-Ning, Patel, Sameer A, Boraas, Marcia, Chang, Eric I, Topham, Neal S, Egleston, Brian L

“…Time to surgery (TTS) is of concern to patients and clinicians, but controversy surrounds its effect on breast cancer survival. There remains little national…”
Get more information

Survival among patients with advanced renal cell carcinoma in the pretargeted versus targeted therapy eras by Li, Pengxiang, Wong, Yu‐Ning, Armstrong, Katrina, Haas, Naomi, Subedi, Prasun, Davis‐Cerone, Margaret, Doshi, Jalpa A.

“…Between December 2005 and October 2009, FDA approved six targeted therapies shown to significantly extend survival for advanced renal cell carcinoma (RCC)…”
Get full text

Radium‐223 Safety, Efficacy, and Concurrent Use with Abiraterone or Enzalutamide: First U.S. Experience from an Expanded Access Program by Sartor, Oliver, Vogelzang, Nicholas J., Sweeney, Christopher, Fernandez, Daniel C., Almeida, Fabio, Iagaru, Andrei, Brown, Alan, Smith, Matthew R., Agrawal, Manish, Dicker, Adam P., Garcia, Jorge A., Lutzky, Jose, Wong, Yu‐Ning, Petrenciuc, Oana, Gratt, Jeremy, Shore, Neal D., Morris, Michael J.

“…Background In the phase III ALSYMPCA trial, metastatic castration‐resistant prostate cancer (mCRPC) patients had few prior life‐prolonging therapies. Following…”
Get full text

Preoperative Delays in the US Medicare Population With Breast Cancer by BLEICHER, Richard J, RUTH, Karen, SIGURDSON, Elin R, ROSS, Eric, WONG, Yu-Ning, PATEL, Sameer A, BORAAS, Marcia, TOPHAM, Neal S, EGLESTON, Brian L

“…Although no specific delay threshold after diagnosis of breast cancer has been demonstrated to affect outcome, delays can cause anxiety, and surgical waiting…”
Get full text

Multiple myeloma treatment patterns and clinical outcomes in the Latin America Haemato‐Oncology (HOLA) Observational Study, 2008–2016 by Hungria, Vania Tietsche, Martínez‐Baños, Deborah M., Peñafiel, Christian R., Miguel, Carlos E., Vela‐Ojeda, Jorge, Remaggi, Guillermina, Duarte, Fernando B., Cao, Carmen, Cugliari, Maria S., Santos, Telma, Machnicki, Gerardo, Fernandez, Mariana, Grings, Mariana, Ammann, Eric M., Lin, Jennifer H., Chen, Yen‐Wen, Wong, Yu‐Ning, Barreyro, Paula

“…Summary Limited data are available regarding contemporary multiple myeloma (MM) treatment practices in Latin America. In this retrospective cohort study,…”
Get full text

Phase II Trial of Cetuximab With or Without Paclitaxel in Patients With Advanced Urothelial Tract Carcinoma by WONG, Yu-Ning, LITWIN, Samuel, HUDES, Gary, VAUGHN, David, COHEN, Seth, PLIMACK, Elizabeth R, LEE, James, SONG, Wei, DABROW, Michael, BRODY, Marion, TUTTLE, Holly

“…The benefit of salvage chemotherapy is modest in metastatic urothelial cancer. We conducted a randomized, noncomparative phase II study to measure the efficacy…”
Get full text

Survival Associated With Treatment vs Observation of Localized Prostate Cancer in Elderly Men by Wong, Yu-Ning, Mitra, Nandita, Hudes, Gary, Localio, Russell, Schwartz, J. Sanford, Wan, Fei, Montagnet, Chantal, Armstrong, Katrina

“…CONTEXT Prostate-specific antigen screening has led to an increase in the diagnosis and treatment of localized prostate cancer. However, the role of active…”
Get full text

Chemotherapy use and adoption of new agents is affected by age and comorbidities in patients with metastatic colorectal cancer by Vijayvergia, Namrata, Li, Tianyu, Wong, Yu‐Ning, Hall, Michael J., Cohen, Steven J., Dotan, Efrat

“…BACKGROUND The treatment of metastatic colorectal cancer (mCRC) has changed substantially in the last 2 decades, but to the authors' knowledge, the effect of…”
Get full text

Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System by Yamoah, Kosj, Lee, Kyung Min, Awasthi, Shivanshu, Alba, Patrick R, Perez, Cristina, Anglin-Foote, Tori R, Robison, Brian, Gao, Anthony, DuVall, Scott L, Katsoulakis, Evangelia, Wong, Yu-Ning, Markt, Sarah C, Rose, Brent S, Burri, Ryan, Wang, Carrie, Aboiralor, Okoduwa, Fink, Angelina K, Nickols, Nicholas G, Lynch, Julie A, Garraway, Isla P

“…Prostate cancer (PCa) disproportionately affects African American men, but research evaluating the extent of racial and ethnic disparities across the PCa…”
Get full text

Latent Class Survival Models Linked by Principal Stratification to Investigate Heterogenous Survival Subgroups Among Individuals With Early-Stage Kidney Cancer by Egleston, Brian L., Uzzo, Robert G., Wong, Yu-Ning

“…Rates of kidney cancer have been increasing, with small incidental tumors experiencing the fastest growth rates. Much of the increase could be due to increased…”
Get full text

Patient-centered recruitment and retention for a randomized controlled study by Chhatre, Sumedha, Jefferson, Ashlie, Cook, Ratna, Meeker, Caitlin R, Kim, Ji Hyun, Hartz, Kayla Marie, Wong, Yu-Ning, Caruso, Adele, Newman, Diane K, Morales, Knashawn H, Jayadevappa, Ravishankar

“…Recruitment and retention strategies for patient-centered outcomes research are evolving and research on the subject is limited. In this work, we present a…”
Get full text